Literature DB >> 10818536

beta-Amyloid vasoactivity and proinflammation in microglia can be blocked by cGMP-elevating agents.

D Paris1, T Town, T Parker, J Humphrey, M Mullan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10818536     DOI： 10.1111/j.1749-6632.2000.tb06397.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  NF-κB Upregulates Type 5 Phosphodiesterase in N9 Microglial Cells: Inhibition by Sildenafil and Yonkenafil.

Authors:  Siqi Zhao; Jingyu Yang; Lixin Wang; Shengyi Peng; Jie Yin; Lina Jia; Xiaowei Yang; Zengqiang Yuan; Chunfu Wu
Journal:  Mol Neurobiol       Date:  2015-06-25       Impact factor: 5.590

Review 2.  Alternative Abeta immunotherapy approaches for Alzheimer's disease.

Authors:  Terrence Town
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-04       Impact factor: 4.388

3.  Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner.

Authors:  Thomas W Miller; Jeff S Isenberg; Hubert B Shih; Yichen Wang; David D Roberts
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

4.  Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly.

Authors:  Ashley C Torregrossa; Mayank Aranke; Nathan S Bryan
Journal:  J Geriatr Cardiol       Date:  2011-12       Impact factor: 3.327

Review 5.  CD47 in the Brain and Neurodegeneration: An Update on the Role in Neuroinflammatory Pathways.

Authors:  Seyed Mohammad Gheibihayat; Ricardo Cabezas; Nikita G Nikiforov; Tannaz Jamialahmadi; Thomas P Johnston; Amirhossein Sahebkar
Journal:  Molecules       Date:  2021-06-28       Impact factor: 4.411

6.  Role of phosphodiesterase 5 in synaptic plasticity and memory.

Authors:  Daniela Puzzo; Salvatore Sapienza; Ottavio Arancio; Agostino Palmeri
Journal:  Neuropsychiatr Dis Treat       Date:  2008-04       Impact factor: 2.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.